GlassScriptPhysician profile
Gaurav Rao
NPI 1083957021
$32,758.53
in general payments reported to CMS, 2019-2025
20 companies · $8,156 in 2025
The $8,156 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $1,650 · 2021: $451 · 2022: $5,228 · 2023: $12K · 2024: $4,585 · 2025: $8,156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Food and Beverage: $7,617 · Consulting Fee: $4,900 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,164.96 |
| Food and Beverage | $7,617.12 |
| Consulting Fee | $4,900.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,704.62 | 2020-2025 | Optis, Cardiomems, Mitraclip |
| Zoll Circulation INC | $7,350.65 | 2023-2025 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Medtronic, INC. | $6,185.38 | 2022-2025 | Symplicity G3, Corevalve Evolut R, Onyx Frontier |
| Penumbra, INC. | $5,553.32 | 2021-2023 | Indigo System |
| Inari Medical, INC. | $1,447.93 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Edwards Lifesciences Corporation | $1,376.29 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $618.38 | 2020-2025 | Avvigo Guidance System, Rotapro, Rotablator Rotational Atherectomy System Console Kit |
| Abiomed | $556.71 | 2023-2025 | Impella |
| Acist Medical Systems, INC. | $465.23 | 2023 | |
| Philips North America LLC | $340.24 | 2023-2024 | (Br0) Coronary Atherectomy, (6571) Eagle Eye |
| Shockwave Medical, INC | $255.90 | 2024-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Stryker Corporation | $209.02 | 2025 | Flowtriever |
| Ge Healthcare | $173.70 | 2020 | |
| Cook Medical LLC | $156.91 | 2022 | |
| Pfizer INC. | $122.55 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $110.60 | 2025 | Lifevest |
| Siemens Medical Solutions USA, INC. | $60.52 | 2023 | Artis Icono Floor |
| Astrazeneca Pharmaceuticals LP | $27.52 | 2021-2024 | Farxiga |
| Cardiovascular Systems INC. | $24.35 | 2022 | |
| Lantheus Medical Imaging, INC. | $18.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaurav Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.